The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine

• Hep-c was designed by nanochelating technology (which is registered in USPTO). • Effect of Hep-c adjuvant on HBS vaccine induced immune responses was evaluated. • Vaccination with Hep-c increased lymphocyte proliferation and IFN-γ cytokine levels.